Scholarlink

<p>Drug-induced liver injury (DILI) represents a major clinical challenge, often limiting the therapeutic use of agents such as acitretin, a second-generation retinoid prescribed for psoriasis. This study established and characterized a rat model of acitretin-induced hepatotoxicity, aiming to explore potential biomarkers and mechanisms of protection. Fifty male Sprague–Dawley rats were divided into five groups: control, acitretin, melatonin + acitretin, naringenin + acitretin, and combination treatment. Biochemical liver function tests, oxidative stress markers, inflammatory cytokines, histopathology, immunohistochemistry, and gene expression analyses were performed. Acitretin administration significantly elevated serum ALT, AST, ALP, LDH, and bilirubin levels, with concurrent reductions in serum albumin.Query Oxidative stress markers (MDA, nitrite) were increased, while antioxidant defenses (GSH, catalase) were compromised. Acitretin activated the HMGB1/TLR4/NF-κB pathway, elevated TNF-α and IL-6 levels, and triggered JAK/STAT3 signaling, contributing to inflammation, apoptosis via caspase-3 activation, and early fibrotic changes marked by TGF-β and MMP-9 upregulation. Treatment with melatonin and naringenin significantly mitigated these alterations, reducing oxidative stress, inflammation, apoptosis, and fibrogenesis. Notably, combination therapy provided superior hepatoprotection compared to individual treatments, suggesting a synergistic effect. These findings propose melatonin and naringenin as promising adjuncts to enhance the safety profile of acitretin therapy in clinical practice.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Protective effects of melatonin and naringenin against acitretin induced hepatotoxicity via modulation of oxidative stress and inflammatory signaling

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年8月27日

查看全文
  • Samia S. Sokar,
  • Sally E. Abu-Risha,
  • Mahmoud Abdelrahman Alkabbani,
  • Laila A. Ramadan,
  • Alaa E. Elsisi

摘要

Drug-induced liver injury (DILI) represents a major clinical challenge, often limiting the therapeutic use of agents such as acitretin, a second-generation retinoid prescribed for psoriasis. This study established and characterized a rat model of acitretin-induced hepatotoxicity, aiming to explore potential biomarkers and mechanisms of protection. Fifty male Sprague–Dawley rats were divided into five groups: control, acitretin, melatonin + acitretin, naringenin + acitretin, and combination treatment. Biochemical liver function tests, oxidative stress markers, inflammatory cytokines, histopathology, immunohistochemistry, and gene expression analyses were performed. Acitretin administration significantly elevated serum ALT, AST, ALP, LDH, and bilirubin levels, with concurrent reductions in serum albumin.Query Oxidative stress markers (MDA, nitrite) were increased, while antioxidant defenses (GSH, catalase) were compromised. Acitretin activated the HMGB1/TLR4/NF-κB pathway, elevated TNF-α and IL-6 levels, and triggered JAK/STAT3 signaling, contributing to inflammation, apoptosis via caspase-3 activation, and early fibrotic changes marked by TGF-β and MMP-9 upregulation. Treatment with melatonin and naringenin significantly mitigated these alterations, reducing oxidative stress, inflammation, apoptosis, and fibrogenesis. Notably, combination therapy provided superior hepatoprotection compared to individual treatments, suggesting a synergistic effect. These findings propose melatonin and naringenin as promising adjuncts to enhance the safety profile of acitretin therapy in clinical practice.